Related Experiment Video
Updated: Jan 14, 2026
06:04
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
Published on: March 6, 2018
17.5K
Review of Current Guidelines and Innovations in Benign Prostatic Hyperplasia Evaluation and Management.
Jaspreet S Sandhu1, Felix Cheung2
1Department of Surgery/Urology, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancers, 353 East 68th Street, New York, NY 10065, USA.
The Urologic Clinics of North America
|October 17, 2025
Summary
This review covers the latest benign prostatic hyperplasia (BPH) management strategies, including new diagnostic tools like AI and various surgical options. It emphasizes personalized treatment approaches for optimal patient outcomes.
Area of Science:
- Urology
- Medical Technology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition affecting aging men.
- Current BPH management involves a range of treatments, but advancements are continually emerging.
Purpose of the Study:
- To review recent advancements in BPH evaluation and management.
- To highlight updates from the 2023 American Urologic Association Guidelines.
- To discuss emerging diagnostic and therapeutic modalities.
Main Methods:
- Comprehensive literature review focusing on recent studies and guidelines.
- Analysis of diagnostic approaches including clinical assessment, imaging, AI, and machine learning.
- Categorization of surgical interventions from minimally invasive to definitive procedures.
Main Results:
- An individualized, algorithmic diagnostic approach is recommended.
- Surgical options range from prostatic urethral lift and water vapor therapy to holmium laser enucleation and robotic prostatectomy.
- Artificial intelligence and machine learning show emerging roles in diagnosis.
Conclusions:
- BPH management requires a personalized approach based on the latest evidence.
- A spectrum of surgical treatments exists to suit individual patient needs.
- Future BPH care will likely involve novel therapeutics, precision medicine, and cost-effectiveness analysis.
Related Concept Videos
01:20Disorders of the Male Reproductive System
4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
01:30Urinary Tract Calculi III: Medical Management
193
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
193
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
250
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
250
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
554
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
554
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
371
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
371
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
457
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
457